Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
HistoSonics
MedTech
HistoSonics nets de novo nod for liver tumor-blasting ultrasound
For the first time, the FDA has greenlighted histotripsy technology, which uses ultrasound waves to noninvasively destroy a designated tumor.
Andrea Park
Oct 9, 2023 3:00pm
Fierce Medtech's 2022 Fierce 15
Mar 20, 2023 3:00am
HistoSonics scores $85M for tumor-blasting ultrasound
Dec 13, 2022 12:41pm
GE to sell HistoSonics' soundwave therapy for liver cancer
May 23, 2022 11:09am